You are here: Industry Insights > revenue

News List

GSK Pharma announces results for the quarter ended June 30, 2020 expresspharma
July 30, 2020
GlaxoSmithKline Pharmaceuticals declared its financial results for the quarter ended June 30, 2020. Revenue for the quarter came in at Rs 649 crores as against Rs 787.97 crores for the same period last year.
Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr expresspharma
July 27, 2020
The company's Research Services business reported flat revenue growth at Rs 422 Crore due to slowdown of operations impacted by the COVID-19 crisis.
Syngene announces Q1 FY21 results; Revenue stands at Rs. 437 Cr expresspharma
July 24, 2020
The company posted quarterly revenue of Rs. 437 Cr, in line with guidance: Profit After Tax, was impacted less than expected, at Rs. 58 Cr for the quarter.
Glenmark’s consolidated revenue rises to Rs 27,674.89 million for Q4 FY 2019-20 expresspharma
June 28, 2020
Glenmark Pharmaceuticals, a research-led global integrated pharmaceutical company announced its financial results for the fourth quarter and year ended March 31, 2020.
Jubilant Life Sciences posts Rs 260.49 cr profit for Jan-Mar expresspharma
June 03, 2020
Drug firm Jubilant Life Sciences reported a consolidated net profit of Rs 260.49 crore for the quarter ended on March 31, 2020, driven by robust sales in the pharmaceuticals segment.
Strides Pharma Q4 results: Posts net loss of Rs 206.57 crore expresspharma
May 21, 2020
The company's consolidated revenue from operations stood at Rs 618.64 crore for the quarter under consideration. It was Rs 616.18 crore for the same period year ago, it added.
GSK reports revenue growth at 3 per cent in quarter financial results expresspharma
May 19, 2020
Board of Directors of the Company recommends a Dividend of Rs. 40 per equity share (including special dividend of Rs. 20 per equity share) for the 12 months period ended March 31, 2020.
Syngene Intl gains after Q4 PAT rises 20 per cent to Rs 120 cr expresspharma
May 14, 2020
Syngene's consolidated EBITDA jumped 24 per cent to Rs 225 crore in Q4 March 2020 from Rs 181 crore in Q4 March 2019.
AZ delivers strong first quarter pharmatimes
May 05, 2020
AstraZeneca says it has delivered “a quarter of strong revenue and profit growth, reflecting the immense efforts of supply chain, commercial and other colleagues around the world to get vital medicines to patients”.
Cryoport Reports Record Revenue contractpharma
March 09, 2020
Revenue from commercial therapies increased 295% to $8.3 million in 2019.